Stocks and InvestingStocks and Investing
Wed, November 20, 2019
Tue, November 19, 2019
Mon, November 18, 2019
Fri, November 15, 2019
Thu, November 14, 2019
Wed, November 13, 2019

Madhu Kumar Maintained (ARWR) at Strong Buy with Increased Target to $59 on, Nov 13th, 2019


Published on 2024-10-26 18:14:08 - WOPRAI, Madhu Kumar
  Print publication without navigation


Madhu Kumar of B. Riley Securities, Maintained "Arrowhead Pharmaceuticals, Inc." (ARWR) at Strong Buy with Increased Target from $46 to $59 on, Nov 13th, 2019.

Madhu has made no other calls on ARWR in the last 4 months.



There are 2 other peers that have a rating on ARWR. Out of the 2 peers that are also analyzing ARWR, 1 agrees with Madhu's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Joel Beatty of "Baird" Downgraded from Buy to Hold and Held Target at $39 on, Thursday, October 24th, 2019


This is the rating of the analyst that currently disagrees with Madhu


  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy with Increased Target to $45 on, Tuesday, October 22nd, 2019